Oscar Health (NYSE:OSCR) Earns Underperform Rating from Analysts at Jefferies Financial Group

Research analysts at Jefferies Financial Group started coverage on shares of Oscar Health (NYSE:OSCR) in a research note issued on Tuesday, MarketBeat Ratings reports. The firm set an “underperform” rating and a $12.00 price target on the stock. Jefferies Financial Group’s target price would indicate a potential downside of 27.56% from the company’s previous close.

OSCR has been the subject of several other research reports. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Piper Sandler restated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $16.57 on Tuesday. The company has a market capitalization of $4.10 billion, a PE ratio of -276.08 and a beta of 1.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a twelve month low of $7.50 and a twelve month high of $23.79. The firm has a fifty day simple moving average of $16.80 and a 200 day simple moving average of $17.77.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the business posted ($0.29) earnings per share. The business’s revenue was up 68.3% on a year-over-year basis. On average, sell-side analysts forecast that Oscar Health will post -0.01 EPS for the current year.

Insider Buying and Selling

In other Oscar Health news, Vice Chairman Joshua Kushner purchased 276,040 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the acquisition, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. The trade was a 5.80 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the transaction, the director now owns 89,512 shares of the company’s stock, valued at $1,526,179.60. This trade represents a 21.83 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Versor Investments LP purchased a new stake in Oscar Health in the third quarter worth $787,000. Janney Montgomery Scott LLC bought a new position in Oscar Health during the third quarter worth about $988,000. Algert Global LLC raised its position in shares of Oscar Health by 63.3% in the third quarter. Algert Global LLC now owns 369,685 shares of the company’s stock valued at $7,841,000 after purchasing an additional 143,346 shares during the period. Point72 Asset Management L.P. boosted its holdings in Oscar Health by 30.3% in the 3rd quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company’s stock worth $25,709,000 after buying an additional 281,858 shares during the period. Finally, Parkman Healthcare Partners LLC purchased a new stake in shares of Oscar Health during the third quarter worth $5,302,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.